Quantitative framework for model evaluation in microbiology research using Pseudomonas aeruginosa and cystic fibrosis infection as a test case
10.1128/mbio.03042-19 · doi-reference
Development of a flow chamber system for the reproducible in vitro analysis of biofilm formation on implant materials
10.1371/journal.pone.0172095 · doi-reference
Dynamics of initial subgingival colonization of ‘pristine’peri‐implant pockets
10.1111/j.1600-0501.2005.01194.x · doi-reference
Periimplant diseases: where are we now?--Consensus of the Seventh European Workshop on Periodontology
10.1111/j.1600-051x.2010.01674.x · doi-reference
Structure, viability and bacterial kinetics of an in vitro biofilm model using six bacteria from the subgingival microbiota
10.1111/j.1600-0765.2010.01341.x · doi-reference
An in vitro biofilm model associated to dental implants: structural and quantitative analysis of in vitro biofilm formation on different dental implant surfaces
10.1016/j.dental.2014.07.008 · doi-reference
Device-associated infections: a macroproblem that starts with microadherence
10.1086/323130 · doi-reference
Polyspecies biofilm formation on implant surfaces with different surface characteristics
10.1590/1678-7757201302312 · doi-reference
Development and characterization of an oral multispecies biofilm implant flow chamber model
10.1371/journal.pone.0196967 · doi-reference
Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum
10.1038/srep43321 · doi-reference
Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung
10.1099/jmm.0.45969-0 · doi-reference
Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum
10.1099/jmm.0.019984-0 · doi-reference
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
10.1183/16000617.0055-2021 · doi-reference
Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries
10.1016/j.jcf.2010.08.002 · doi-reference
Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis
10.1038/s41467-021-21748-6 · doi-reference
Pathogenesis of group A streptococcal infections
10.1128/cmr.13.3.470 · doi-reference
Assessing the role of pharyngeal cell surface glycans in group A Streptococcus biofilm formation
10.3390/antibiotics9110775 · doi-reference
An optimised GAS-pharyngeal cell biofilm model
10.1038/s41598-021-87377-7 · doi-reference
Streptococcus pyogenes biofilm growth in vitro and in vivo and its role in colonization, virulence and genetic exchange
10.1093/infdis/jiu058 · doi-reference
Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation
10.1111/j.1365-2958.2007.05704.x · doi-reference
Characterization of biofilm formation by clinically relevant serotypes of group A streptococci
10.1128/aem.72.4.2864-2875.2006 · doi-reference
Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage
10.1186/1471-2431-12-3 · doi-reference
Oral candidiasis: a disease of opportunity
10.3390/jof6010015 · doi-reference
Antibacterial and remineralizing nanocomposite inhibit root caries biofilms and protect root dentin hardness at the margins
10.1016/j.jdent.2020.103344 · doi-reference
Candida albicans promotes tooth decay by inducing oral microbial dysbiosis
10.1038/s41396-020-00823-8 · doi-reference
Central role of the early colonizer Veillonella sp in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel
10.1128/jb.01631-09 · doi-reference
Dental biofilm and laboratory microbial culture models for cariology research
10.3390/dj5020021 · doi-reference
Catheter associated urinary tract infections
10.1186/2047-2994-3-23 · doi-reference
